Managing clinical research for allergic diseases and autoimmune disorders
Official title: RhoFED CDSMC
Funded at Rho Federal Systems Division, INC. · NIH-11083136 · Data updated 2026-11-12
This study is working on making clinical trials for allergies, asthma, and autoimmune diseases better and safer, so patients like you can have a smoother experience and possibly find more effective treatments.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rho Federal Systems Division, INC. NIH-funded |
| Lab location | 1 site (Durham, UNITED STATES) |
| Project start | May 8, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $9,045,964 |
| NIH project number | 5U01AI178773-03 |
| Project ID | NIH-11083136 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals suffering from allergic diseases, asthma, or autoimmune disorders.
✕Less likely to help
Patients with conditions unrelated to allergies or autoimmune disorders may not receive any benefit from this research.
What this research studies
This research focuses on enhancing the management of clinical trials related to allergic diseases, asthma, and autoimmune disorders. It aims to improve data management, safety monitoring, and specimen tracking through innovative technology and best practices. By consolidating clinical support services, the project seeks to ensure continuity and efficiency in clinical research operations. Patients may benefit from improved trial management and potentially more effective treatments as a result of this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and better management of allergic and autoimmune conditions.
How similar studies have gone: Other research has shown success in improving clinical trial management and outcomes through similar innovative approaches.
Where this research is happening
-
Rho Federal Systems Division, INC.
Durham, United States Active
Researchers
- Principal investigator: Schmidt, Peter N. — Rho Federal Systems Division, INC.
- Study coordinator: Schmidt, Peter N.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.